Why Is DANAHER CORP (DHR) Stock Up Today?

Danaher Corp (DHR) rose 5.72% to $189.38 on Friday, driven by a combination of a strong intraday gap and positive developments in its diagnostics segment. The stock opened with a 0.9% gap up from the prior close and climbed steadily through the session, reaching a high of $189.62. The move followed news from its Beckman Coulter Diagnostics division, which launched a new automated urinalysis system to meet rising diagnostic demand.

What Happened

Beckman Coulter Diagnostics announced the launch of the DxU 1800 System, a fully automated urinalysis system featuring a new urine chemistry analyzer and consumables. The system is designed to help laboratories handle increased testing volumes, a key concern in the diagnostics industry. This development comes amid analyst activity, with Guggenheim and Stifel both lowering Danaher's price targets due to concerns over bioprocessing performance. However, the product launch appears to have offset some of the bearish sentiment, particularly in the diagnostics segment of the company.

What The Data Shows

The stock's intraday session showed a strong upward trajectory, with volume reaching 2.3 million shares, or 0.5 times the 3-month average. The stock opened at $180.74 and climbed to $189.62 at 11:25 AM ET. The 52-week range for Danaher is $160.93 to $242.80, and the stock closed near its high. On the options front, put premiums outpaced call premiums by $1.5 million, with the largest single print at $755,000. Additionally, the 52-week tape showed one fresh 52-week low and 15 fresh 52-week highs on the same day.

What To Watch

Danaher is currently trading with a market cap of $125.8 billion and a P/E ratio of 31.9. Investors should monitor the company’s earnings report, as well as continued analyst coverage and any further developments in the bioprocessing and diagnostics segments.